| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-07 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-07 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.17 | 5e-07 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-07 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.17 | 7e-07 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.16 | 7e-07 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-06 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.16 | 3e-06 |